Product Code: GVR-4-68040-267-9
Bioprocess Monitoring Market Growth & Trends:
The global bioprocess monitoring market is anticipated to reach USD 6.29 billion by 2030 and is projected to grow at a CAGR of 9.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. Several factors are driving the market growth. More accurate and trustworthy bioprocess monitoring instruments are required as the market for cutting-edge and effective biopharmaceutical products-such as vaccines, recombinant proteins, and monoclonal antibodies-continues to grow. These goods are essential for improving public health and treating a range of medical issues. Moreover, it is anticipated that the growing number of alliances and collaborations among industry participants will support market expansion. For instance, Beckman Coulter Life Sciences and Flownamics established a strategic alliance in August 2022 to create a cutting-edge, automated solution for the real-time monitoring and management of bioprocess cultures. This collaboration combines Vi-CELL BLU Cell Viability Analyzer with Flownamics' Seg-Flow S3 Automated On-Line, aiming to enhance the efficiency and accuracy of bioprocess monitoring.
There are several reasons for the market expansion for bioprocess monitoring, Still, one of the main ones is the notable rise in capital expenditures made by pharmaceutical companies for the creation and manufacturing of biologics. The ability of biologics to treat a wide range of illnesses and enhance public health has made them more well-known in recent years. For instance, in January 2024, the multinational biopharmaceutical giant AbbVie invested USD 223 million in its Singapore manufacturing location to improve its biologics manufacturing capabilities. Pharmaceutical companies are making significant investments in R&D, manufacturing capacity, and regulatory compliance to bring these biologics to market as they work to create novel treatments.
In addition, government programs and financial support for biotechnology research have been crucial in promoting creativity and expansion in the bioprocess monitoring industry. The creation of cutting-edge technologies and their commercialization are the results of partnerships between government, business, and academia.
The biotechnology industry's boom in research and development (R&D) has greatly contributed to the market expansion for bioprocess monitoring. The development of cutting-edge tools and methods brought about by this surge in investment and creativity has completely changed how bioprocesses are observed and managed. The market for bioprocess monitoring is now growing quickly because of the sophisticated instruments and techniques that make it possible to measure several parameters precisely and efficiently while biological products are being produced.
Bioprocess Monitoring Market Report Highlights:
- Based on product, the reagents & kits segment led the market with the largest revenue share of 70.31% share in 2023, due to the high demand for personalized medicines. On the other hand, the software segment is expected to grow at the fastest CAGR during the forecast period
- Based on application, the host cell residual DNA/protein quantitation segment held the market with the largest revenue share of 30.88% in 2023. On the other hand, the mycoplasma detection segment is expected to grow at the fastest CAGR during the forecast period
- Based on end-use, the pharmaceutical & biotechnology companies led the market with the largest revenue share of 46.90% in 2023, and CMOs & CROs segment is expected to grow at a significant CAGR during the forecast period
- North America dominated the market with the revenue share of 43.24% in 2023, driven by rising demand for advanced technology, increasing regulatory compliance, and a focus on improving product quality
- Asia Pacific is expected to grow at the fastest CAGR over the forecast period, this upsurge is attributed to the growing biotechnology & pharmaceutical sectors within the region, propelled by factors such as heightened healthcare spending and the expansion of research & development activities
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End-use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. The rising demand for personalized medicine
- 3.2.1.2. Increased complexity of biologics
- 3.2.1.3. Growing concerns over cell culture contamination
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High initial investment and maintenance costs
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Bioprocess Monitoring Market: Product Business Analysis
- 4.1. Segment Dashboard
- 4.2. Global Bioprocess Monitoring Market Product Movement Analysis
- 4.3. Global Bioprocess Monitoring Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Reagents & Kits
- 4.4.1. Global Reagents & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Instruments
- 4.5.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Software
- 4.6.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Bioprocess Monitoring Market: Application Business Analysis
- 5.1. Segment Dashboard
- 5.2. Global Bioprocess Monitoring Market Application, Movement Analysis
- 5.3. Global Bioprocess Monitoring Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Host Cell Residual DNA/Protein Quantitation
- 5.4.1. Global Host Cell Residual DNA/Protein Quantitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Mycoplasma Detection
- 5.5.1. Global Mycoplasma Detection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Viral Titer Determination
- 5.6.1. Global Viral Titer Determination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Adventitious Virus Testing
- 5.7.1. Globa Adventitious Virus Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Other Applications
- 5.8.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Bioprocess Monitoring Market: End-use Business Analysis
- 6.1. Segment Dashboard
- 6.2. Global Bioprocess Monitoring Market End-use Movement Analysis
- 6.3. Global Bioprocess Monitoring Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. CROs & CMOs
- 6.5.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Academic & Research Institutes
- 6.6.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Bioprocess Monitoring Market: Regional Estimates & Trend Analysis by Product, Application, & End-use
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. UK Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Germany Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Australia Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Thailand Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. South Korea Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Mexico
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Mexico Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. Argentina
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Argentina Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Bioprocess Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Participant's Overview
- 8.4.1. Thermo Fisher Scientific Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. QIAGEN
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. F. Hoffmann-La Roche Ltd
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Bio-Rad Laboratories, Inc.
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Bio-Techne.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Enzo Life Sciences, Inc.,
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Maravai LifeSciences.
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Lonza
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Applied Biological Materials Inc.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives